A. G. Ergül Et Al. , "Novel potent benzimidazole-based microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C4 synthase," European Journal of Medicinal Chemistry , vol.231, 2022
Ergül, A. G. Et Al. 2022. Novel potent benzimidazole-based microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C4 synthase. European Journal of Medicinal Chemistry , vol.231 .
Ergül, A. G., Maz, T. G., Kretzer, C., Olğaç, A., Jordan, P. M., Çalışkan, B., ... Werz, O.(2022). Novel potent benzimidazole-based microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C4 synthase. European Journal of Medicinal Chemistry , vol.231.
Ergül, Azize Et Al. "Novel potent benzimidazole-based microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C4 synthase," European Journal of Medicinal Chemistry , vol.231, 2022
Ergül, Azize G. Et Al. "Novel potent benzimidazole-based microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C4 synthase." European Journal of Medicinal Chemistry , vol.231, 2022
Ergül, A. G. Et Al. (2022) . "Novel potent benzimidazole-based microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C4 synthase." European Journal of Medicinal Chemistry , vol.231.
@article{article, author={Azize Gizem Ergül Et Al. }, title={Novel potent benzimidazole-based microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C4 synthase}, journal={European Journal of Medicinal Chemistry}, year=2022}